Jisun Lee

Gyeonggi-do, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Nonclinical safety evaluation strategies for mRNA/LNPs platform agents: Evidence from comprehensive animal toxicity studies.

Nonclinical safety evaluation strategies for mRNA/LNPs platform agents: Evidence from comprehensive animal toxicity studies.

Journal: Toxicology letters

Published: March 24, 2026

Optimized Lipid Nanoparticles with Tail-Modified Ionizable Lipids for Safer mRNA Delivery.

Optimized Lipid Nanoparticles with Tail-Modified Ionizable Lipids for Safer mRNA Delivery.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 04, 2026

Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy.

Take Five: harmonization in personalized cancer vaccines for cancer immunotherapy.

Journal: Experimental & molecular medicine

Published: December 14, 2025

Comparative analysis of expression, immunogenicity, and safety profiles between linear and circular RNA vaccine platforms.

Comparative analysis of expression, immunogenicity, and safety profiles between linear and circular RNA vaccine platforms.

Journal: Molecular therapy. Nucleic acids

Published: October 21, 2025

Repositioning neutrophils in cancer immunotherapy: From innate defenders to antibody-driven effectors.

Repositioning neutrophils in cancer immunotherapy: From innate defenders to antibody-driven effectors.

Journal: Seminars in hematology

Published: October 13, 2025

A novel mRNA-based multi-cytokine strategy to reprogram the peritoneal tumor microenvironment in ovarian cancer.

A novel mRNA-based multi-cytokine strategy to reprogram the peritoneal tumor microenvironment in ovarian cancer.

Journal: Journal of nanobiotechnology

Published: August 14, 2025

Integration of TLR7/8 agonists into lipid nanoparticles enhances antigen-specific immune responses to N1-methyl-Ψ-modified mRNA-LNP vaccines.

Integration of TLR7/8 agonists into lipid nanoparticles enhances antigen-specific immune responses to N1-methyl-Ψ-modified mRNA-LNP vaccines.

Journal: Journal of biological engineering

Published: July 04, 2025

Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.

Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer.

Journal: International journal of oncology

Published: June 16, 2025

ApoE deficiency protects from mRNA vaccine-induced mitochondrial dysfunction at the injection site under metabolic stress.

ApoE deficiency protects from mRNA vaccine-induced mitochondrial dysfunction at the injection site under metabolic stress.

Journal: Theranostics

Published: June 13, 2025

Comparative immunologic profiling of mRNA and protein-conjugated vaccines: acute inflammatory responses and anti-PEG antibody production.

Comparative immunologic profiling of mRNA and protein-conjugated vaccines: acute inflammatory responses and anti-PEG antibody production.

Journal: Animal cells and systems

Published: June 12, 2025

DNA-PKcs orchestrates CTLA-4 depletion-induced senescence in cancer cells.

DNA-PKcs orchestrates CTLA-4 depletion-induced senescence in cancer cells.

Journal: Cell death & disease

Published: May 13, 2025

Beyond Annual Averages: Rethinking Metrics For Emergency Department Crowding And Capacity Planning.

Beyond Annual Averages: Rethinking Metrics For Emergency Department Crowding And Capacity Planning.

Journal: The Journal of emergency medicine

Published: April 29, 2025

Showing 1-12 of 52

Last Updated: 09/26/2026